SEC Filings | Decibel Therapeutics, Inc.

Filing date	Form	Description	View
September 17, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-036500.pdf 0000899243-21-036500.rtf 0000899243-21-036500.xls View HTML
August 18, 2021	3	Initial filing by director officer or owner of more than ten percent.	0000899243-21-033459.pdf 0000899243-21-033459.rtf 0000899243-21-033459.xls View HTML
August 18, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-033466.pdf 0000899243-21-033466.rtf 0000899243-21-033466.xls View HTML
August 17, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-249253.pdf 0001193125-21-249253.rtf 0001193125-21-249253.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-21-042863.pdf 0001564590-21-042863.rtf 0001564590-21-042863.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 3, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-181348.pdf 0001193125-21-181348.rtf 0001193125-21-181348.xls View HTML
June 3, 2021	3	Initial filing by director officer or owner of more than ten percent.	0000899243-21-021806.pdf 0000899243-21-021806.rtf 0000899243-21-021806.xls View HTML
June 3, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-021812.pdf 0000899243-21-021812.rtf 0000899243-21-021812.xls View HTML
May 13, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-21-027531.pdf 0001564590-21-027531.rtf 0001564590-21-027531.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
April 13, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-114755.pdf 0001193125-21-114755.rtf 0001193125-21-114755.xls View HTML

Data provided by Kaleidoscope.

Main Corporate Nav